[go: up one dir, main page]

MX2010007607A - (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] ciclohepten-5iliden)-propil}-fenil}-metilsulfon amida como modulador de receptor glucocorticoide para el tratamiento de reumatoide. - Google Patents

(e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] ciclohepten-5iliden)-propil}-fenil}-metilsulfon amida como modulador de receptor glucocorticoide para el tratamiento de reumatoide.

Info

Publication number
MX2010007607A
MX2010007607A MX2010007607A MX2010007607A MX2010007607A MX 2010007607 A MX2010007607 A MX 2010007607A MX 2010007607 A MX2010007607 A MX 2010007607A MX 2010007607 A MX2010007607 A MX 2010007607A MX 2010007607 A MX2010007607 A MX 2010007607A
Authority
MX
Mexico
Prior art keywords
treatment
methynsulfon
5ylidene
dibenzo
aza
Prior art date
Application number
MX2010007607A
Other languages
English (en)
Inventor
Matthew William Carson
Michael Joseph Coghlan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2010007607A publication Critical patent/MX2010007607A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere al Compuesto (I) o una sal del mismo farmacéuticamente aceptable; composiciones farmacéuticas que comprenden el Compuesto (I) en combinación con uno o más portadores, excipientes o diluyentes farmacéuticamente aceptables; y describe métodos para el tratamiento de enfermedades inflamatorias o inmunes que comprenden administrar a un paciente en necesidad del mismo, una cantidad efectiva del Compuesto (I) o una sal del mismo farmacéuticamente aceptable. (ver fórmula (I)).
MX2010007607A 2008-01-11 2009-01-08 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] ciclohepten-5iliden)-propil}-fenil}-metilsulfon amida como modulador de receptor glucocorticoide para el tratamiento de reumatoide. MX2010007607A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2052008P 2008-01-11 2008-01-11
PCT/US2009/030374 WO2009089312A1 (en) 2008-01-11 2009-01-08 (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid

Publications (1)

Publication Number Publication Date
MX2010007607A true MX2010007607A (es) 2010-08-23

Family

ID=40456776

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007607A MX2010007607A (es) 2008-01-11 2009-01-08 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] ciclohepten-5iliden)-propil}-fenil}-metilsulfon amida como modulador de receptor glucocorticoide para el tratamiento de reumatoide.

Country Status (13)

Country Link
US (1) US8101761B2 (es)
EP (1) EP2231676B1 (es)
JP (1) JP2011525474A (es)
KR (1) KR101237296B1 (es)
CN (1) CN101910179B (es)
AT (1) ATE522537T1 (es)
AU (1) AU2009204155A1 (es)
BR (1) BRPI0906945A2 (es)
CA (1) CA2711885A1 (es)
EA (1) EA017288B1 (es)
ES (1) ES2370148T3 (es)
MX (1) MX2010007607A (es)
WO (1) WO2009089312A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011081173A1 (ja) * 2009-12-29 2011-07-07 協和発酵キリン株式会社 四環系化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2603713B1 (fr) 1986-09-10 1992-07-24 Canon Kk Derive nouveau de 5h-dibenzo(a,d)cycloheptane-(ene)ylidene, son procede de production et support electrophotographique photosensible le contenant
JPH01161245A (ja) 1987-12-18 1989-06-23 Canon Inc 電子写真感光体
US4999363A (en) 1988-06-09 1991-03-12 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
US5093210A (en) 1989-06-30 1992-03-03 Ricoh Company, Ltd. Electroluminescent device
US5378701A (en) 1991-12-27 1995-01-03 Kyowa Hakko Kogyo Tricyclic compounds
CO4980885A1 (es) 1997-12-29 2000-11-27 Ortho Mcneil Pharm Inc Compuestos de trifenilpropanamida utiles en el tratamiento de inflamaciones y metodos para preparar dicho compuesto
US7056911B1 (en) 1999-01-26 2006-06-06 Dana-Farber Cancer Institute Dibenz[B,F]azepine compounds, pharmaceutical compositions comprising same and methods of use thereof
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
AU2004312293A1 (en) * 2003-12-19 2005-07-21 Eli Lilly And Company Tricyclic steroid hormone nuclear receptor modulators
WO2008008882A2 (en) * 2006-07-14 2008-01-17 Eli Lilly And Company Glucocorticoid receptor modulator and methods of use

Also Published As

Publication number Publication date
CA2711885A1 (en) 2009-07-16
EP2231676B1 (en) 2011-08-31
EA017288B1 (ru) 2012-11-30
EP2231676A1 (en) 2010-09-29
EA201070844A1 (ru) 2011-02-28
US20100280062A1 (en) 2010-11-04
ES2370148T3 (es) 2011-12-13
CN101910179A (zh) 2010-12-08
US8101761B2 (en) 2012-01-24
AU2009204155A1 (en) 2009-07-16
KR101237296B1 (ko) 2013-03-04
ATE522537T1 (de) 2011-09-15
KR20100090808A (ko) 2010-08-17
AU2009204155A8 (en) 2010-07-08
CN101910179B (zh) 2013-06-19
WO2009089312A1 (en) 2009-07-16
BRPI0906945A2 (pt) 2015-07-14
JP2011525474A (ja) 2011-09-22

Similar Documents

Publication Publication Date Title
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
MX2020004099A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
PH12014500386A1 (en) Combination treatment for hepatitis c
WO2010054113A3 (en) Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
EP4327888A3 (en) Oral formulations of cytidine analogs and methods of use thereof
WO2010039977A3 (en) Heteroaryl antagonists of prostaglandin d2 receptors
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
EP3632444A3 (en) Topical lfa-1 antagonists for use in localized treatment of immune related disorders
WO2009106980A3 (en) Indazole derivatives
EA201001253A1 (ru) N,n-дизамещенные аминоалкилбифенилы в качестве антагонистов рецепторов простагландина d
UA97795C2 (uk) Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки
MX2010009623A (es) Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
WO2011009039A3 (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
MX2014005075A (es) Formulaciones de sal de meglumina del acido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxilico.
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
UA99787C2 (en) Lactams as beta secretase inhibitors
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
MX360554B (es) Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2.
MX2010009462A (es) Derivados de indazol.
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
UA102097C2 (ru) Способ лечения воспалительного заболевания с применением соединения, которое нейтрализует gm-csf, и соединения, которое нейтрализует il-17
PH12012501389A1 (en) Hedgehog inhibitors
PH12013500371A1 (en) Therapeutic agent for pain
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease

Legal Events

Date Code Title Description
FG Grant or registration